Drug Repurposing of Metabolic Agents in Malignant Glioma

Area of Science:

• Oncology
• Metabolic pathways
• Drug discovery

Background:

• Gliomas are aggressive brain tumors characterized by poor patient survival.
• Aberrant tumor metabolism is a critical factor in glioma pathogenesis.
• Targeting tumor metabolism presents a promising therapeutic strategy.

Purpose of the Study:

• To review drug repurposing strategies for glioma treatment.
• To identify and discuss potential metabolic drug candidates for gliomas.
• To analyze the advantages and challenges of drug repurposing in glioma research.

Main Methods:

• Literature review on drug repurposing definitions and methods.
• Identification of existing drugs with potential anti-glioma metabolic activity.
• Analysis of candidate drugs including metformin, statins, NSAIDs, disulfiram, and lonidamine.

Main Results:

• Drug repurposing is a viable strategy to target glioma metabolism.
• Several drug classes, including metformin and statins, show promise.
• Metabolic drug repurposing requires careful consideration of benefits and drawbacks.

Conclusions:

• Metabolic drug repurposing holds significant potential for improving glioma treatment outcomes.
• Further research is needed to validate the efficacy and safety of repurposed drugs.
• Understanding drug interactions with tumor metabolism is key to successful repurposing.